GSP Crop Science IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Subject to Sauda |
| 14 Mar 2026 | 0 | 0 |
GSP Crop Science is an emerging player in the agrochemical sector in India. GSP Crop Science IPO is opening on 16 March 2026. The company has 40 years of experience in the agrochemical sector, along with 100 patents and an export network in 37 countries, which gives a huge advantage. In this article, we will analyse GSP Crop Science IPO GMP daily trends and broker research notes to help you decide if it is the right investment choice for you.
GSP Crop Sciences IPO Snapshot
| GSP Crop Science IPO Dates | 16 – 18 March 2026 |
| GSP Crop Science IPO Price | INR 304 – 320 per share |
| Total IPO size | INR 392 – 400 crore |
| Minimum bid (lot size) | 46 shares (INR 14,720) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
GSP Crop Science Financial Performance
| FY 2023 | FY 2024 | FY 2025 | H1 FY 2026 | |
| Revenue | 1,203.31 | 1,152.16 | 1,287.39 | 844.29 |
| Expenses | 1,182.72 | 1,081.67 | 1,191.38 | 739.86 |
| Net income | 17.57 | 55.54 | 81.42 | 81.07 |
| Margin (%) | 1.46 | 4.82 | 6.32 | 9.60 |
GSP Crop Science Valuations Analysis
| FY 2023 | FY 2024 | FY 2025 (Pre-Issue) | FY 2026* (Post-Issue) | |
| EPS | 5.16 | 14.89 | 21.38 | 35.59 |
| PE Ratio | – | – | 14.22 – 14.97 | 8.54 – 8.99 |
| Price/Sales Ratio | – | – | 1.14 – 1.16 | – |
| Price/Book Ratio | – | – | 2.74 – 2.77 | – |
| Current Ratio | 1.34 | 1.30 | 1.30 | – |
| RONW (%) | 4.79 | 15.00 | 18.38 | – |
| EBITDA (%) | 6.75 | 11.32 | 12.74 | – |
GSP Crop Science Benchmarking Against Industry Average
To determine if the GSP Crop Science IPO is priced fairly, we look beyond its peers and compare its performance against Industry Benchmarks (Averages) for the Indian Agrochemical sector.
1. Price-to-Earnings (P/E) Ratio: Deep Value at a Discount
- Industry Benchmark: The average P/E for mid-to-large cap Indian agrochemical companies typically ranges between 22x and 28x.
- GSP Crop Science: At a post-issue P/E of 8.54x – 8.99x, the company is entering the market at a 60% discount compared to the industry average.
- Insight: Even when compared to smaller, specialized players (who often trade at 15x–18x), GSP’s single-digit P/E offers a massive “Margin of Safety” for investors.
2. Return on Net Worth (RONW): Superior Capital Efficiency
- Industry Benchmark: A healthy RONW for a research-driven manufacturing firm in this sector is considered to be 15%.
- GSP Crop Science: With an RONW of 18.38%, GSP fairly above the industry average.
3. Liquidity: Financial Stability
- Industry Benchmark: A Current Ratio of 1.2 to 1.5 is considered the “Sweet Spot” for manufacturing companies to manage working capital.
- GSP Crop Science: Maintaining a steady ratio of 1.30 to 1.34.
Comparative Benchmarking Table
| Metric | Industry Average | GSP Crop Science | Verdict |
| P/E Ratio | 22.0x – 28.0x | 8.54x – 8.99x | Deep Value |
| RONW (%) | 15.00% | 18.38% | Superior |
| EBITDA Margin | 12.0% – 15.0% | 12.74% | In-Line |
| Current Ratio | 1.20 – 1.50 | 1.30 – 1.34 | Healthy |
My View: GSP Crop Science IPO is priced at a fair valuation. While the industry average commands a P/E of over 20x, GSP’s decision to price its issue at under 9x P/E left room for re-rating. When combined with an above-average RONW, the fundamentals present a compelling story.
GSP Crop Science IPO Broker Recommendations – Subscribe or Avoid?
Axis Capital – Not Rated
BP Wealth – Subscribe
SBI Securities – Neutral
Ventura Securities – Subscribe
GSP Crop Science IPO research notes suggest a subscription rating of 50% so far.
GSP Crop Science IPO GMP FAQs
Is GSP Crop Science Available at a Fair Valuation?
Yes, it is available at a discount to the industry average.
What is GSP Crop Science IPO GMP today?
GSP Crop Science IPO GMP today is INR 0 per share.
What is GSP Crop Science Subject to Sauda rate today?
GSP Crop Science Subject to Sauda rate today is INR 0 per application.
What is the Current Trend of GSP Crop Science IPO GMP?
Currently, activity in the grey market is in an early stage; however, as the subscription date draws closer, we may witness increased activity in the premiums.
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.